{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:44:22Z","timestamp":1784259862236,"version":"3.55.0"},"reference-count":21,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2019,5,2]]},"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Tranexamic acid (TXA) reduces bleeding and mortality. Recent trials have demonstrated improved survival with shorter intervals to TXA administration. The aims of this service evaluation were to assess the interval from injury to TXA administration and describe the characteristics of patients who received TXA pre-hospital and in-hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We reviewed Trauma and Audit Research Network records and local trauma registries to identify patients of any age that received TXA at all London Major Trauma Centres and Queen\u2019s Medical Centre, Nottingham, during 2017. We used the 2016 NICE Guidelines (NG39) which state that TXA should be given within 3\u2009hours of injury.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 1018 patients who received TXA, of whom 661 (65%) had sufficient data to assess the time from injury to TXA administration. The median interval was 74\u2009min (IQR: 47\u2013116). 92% of patients received TXA within 3\u2009hours from injury, and 59% within 1\u2009hour. Half of the patients (54%) received prehospital TXA. The median time to TXA administration when given prehospital was 51\u2009min (IQR: 39\u201372), and 112\u2009min (IQR: 84\u2013160) if given in-hospital (p&lt;0.001). In-hospital TXA patients had less haemodynamic derangement and lower base deficit on admission compared with patients given prehospital TXA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Prehospital administration of TXA is associated with a shorter interval from injury to drug delivery. Identifying a proportion of patients at risk of haemorrhage remains a challenge. However, further reinforcement is needed to empower pre-hospital clinicians to administer TXA to trauma patients without overt signs of shock.<\/jats:p><\/jats:sec>","DOI":"10.1136\/emermed-2018-208118","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T21:25:15Z","timestamp":1560979515000},"page":"395-400","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Prehospital tranexamic acid shortens the interval to administration by half in Major Trauma Networks: a service evaluation"],"prefix":"10.1136","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7147-6861","authenticated-orcid":false,"given":"Max E R","family":"Marsden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rossetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A B","family":"Duffield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G D","family":"Woolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P","family":"Buxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Steynberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel R M","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"2024052709093604000_36.7.395.1","unstructured":"Public Health England. Chapter 2: major causes of death and how they have changed, 2017."},{"key":"2024052709093604000_36.7.395.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1705649"},{"key":"2024052709093604000_36.7.395.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60835-5"},{"key":"2024052709093604000_36.7.395.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60278-X"},{"key":"2024052709093604000_36.7.395.5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/SLA.0000000000001393","article-title":"The Impact of a Pan-regional Inclusive Trauma System on Quality of Care","volume":"264","author":"Cole","year":"2016","journal-title":"Ann Surg"},{"key":"2024052709093604000_36.7.395.6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eclinm.2018.07.001","article-title":"Changing the system - major trauma patients and their outcomes in the NHS (England) 2008\u201317","volume":"2-3","author":"Moran","year":"2018","journal-title":"EClinicalMedicine"},{"key":"2024052709093604000_36.7.395.7","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2018-207693"},{"key":"2024052709093604000_36.7.395.8","unstructured":"NICE. Major trauma: Complex fractures. NICE guideline: National Institute for Health and Care Excellence, 2016."},{"key":"2024052709093604000_36.7.395.9","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Shakur","year":"2017","journal-title":"The Lancet"},{"key":"2024052709093604000_36.7.395.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32455-8"},{"key":"2024052709093604000_36.7.395.11","unstructured":"NHS England and NHS Improvement. 2017\/18 and 2018\/19 National Tariff Payment System Annex F: guidance on best practice tariffs, 2016."},{"key":"2024052709093604000_36.7.395.12","unstructured":"The Trauma Audit & Research Network. Performance Comparison: Trauma Care; Case ascertainment, 2018."},{"key":"2024052709093604000_36.7.395.13","unstructured":"The Trauma Audit & Research Network. Procedures manual - England and Wales: TARN, 2018."},{"key":"2024052709093604000_36.7.395.14","unstructured":"NHS England and NHS Improvement. 2017\/18 and 2018\/19 National Tariff Payment System: NHS Improvement, 2018:28."},{"key":"2024052709093604000_36.7.395.15","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aew317"},{"key":"2024052709093604000_36.7.395.16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tracli.2018.05.002","article-title":"Compliance with the European trauma guidelines: an observational single centre study","volume":"26","author":"Rossignol","year":"2019","journal-title":"Transfus Clin Biol"},{"key":"2024052709093604000_36.7.395.17","doi-asserted-by":"crossref","unstructured":"Ng M , Perrott J , Burgess S . Evaluation of tranexamic acid in trauma patients: a retrospective quantitative analysis. Am J Emerg Med 2019;37.doi:10.1016\/j.ajem.2018.06.010","DOI":"10.1016\/j.ajem.2018.06.010"},{"key":"2024052709093604000_36.7.395.18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/bjs.10497","article-title":"Effectiveness of early administration of tranexamic acid in patients with severe trauma","volume":"104","author":"Shiraishi","year":"2017","journal-title":"Br J Surg"},{"key":"2024052709093604000_36.7.395.19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4172\/2329-6887.1000171","article-title":"Systematic review of tranexamic acid adverse reactions","volume":"03","author":"Calapai","year":"2015","journal-title":"J Pharmacovigil"},{"key":"2024052709093604000_36.7.395.20","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"2024052709093604000_36.7.395.21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","article-title":"When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts","volume":"17","author":"Jakobsen","year":"2017","journal-title":"BMC Med Res Methodol"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2018-208118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T16:10:14Z","timestamp":1716826214000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2018-208118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,18]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1136\/emermed-2018-208118"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2018-208118","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]}}}